2B1F_HUMAN » HLA class II histocompatibility antigen, DRB1-15 beta chain

2B1F_HUMAN » HLA class II histocompatibility antigen, DRB1-15 beta chain
Magnify 2B1F_HUMAN » HLA class II histocompatibility antigen, DRB1-15 beta chainEnlarged view of image
3D view in GLMol or JMol

gray dot

Download Coordinates

gray dot

Topology in Plasma membrane
Topologyextracellular side
cytoplasmic side
2B1F_HUMAN » HLA class II histocompatibility antigen, DRB1-15 beta chain » DW2.2/DR2.2;MHC class II antigen DRB1*15;
Hydrophobic Thickness 33.2 ± 1.4 Å
Tilt Angle 1 ± 0°
ΔGtransfer -40.9 kcal/mol
ΔGfold -15.0 kcal/mol
Links UniProtKB, Pfam, Interpro, iHOP, STRING, HGNC, Reactome
Topology Out
TM Segments 228-250 (222-253)
Pathways

Allograft rejection (KEGG)

Antigen processing and presentation (KEGG)

Asthma (KEGG)

Autoimmune thyroid disease (KEGG)

Cell adhesion molecules (KEGG)

Epstein-Barr virus infection (KEGG)

Graft-versus-host disease (KEGG)

Hematopoietic cell lineage (KEGG)

Herpes simplex infection (KEGG)

HTLV-I infection (KEGG)

Immune System (Reactome)

Influenza A (KEGG)

Intestinal immune network for IgA production (KEGG)

Leishmaniasis (KEGG)

Phagosome (KEGG)

Rheumatoid arthritis (KEGG)

Staphylococcus aureus infection (KEGG)

Systemic lupus erythematosus (KEGG)

Toxoplasmosis (KEGG)

Tuberculosis (KEGG)

Type I diabetes mellitus (KEGG)

Viral myocarditis (KEGG)

PDB 1bx2 (B/E=32-222), 2wbj (B/F=30-227), 1ymm (B=30-227)
OPM none
Complexes

MBP:2B1F:DRA:TCA:TRBC1_HUMAN

MBP:2B1F:DRA_HUMAN

2B1F:DRA_HUMAN

Interactions

2B13, Complex: 2B13:2B1F

DMA, Complex: 2B1F:DMA, PubMed

DRA, Complex: 2B1F.2B1G:DRA, PubMed

DRA, Complex: MBP:2B1F:DRA, PDBID: 1BX2

TCA, Complex: MBP:2B1F:DRA:TCA:TRBC1, PDBID: 1YMM

Domains

AA: 42-116, PDBID: 1BX2, Subunit E, Seq Identity:100%, Class II histocompatibility antigen, beta domain

AA: 126-209, PDBID: 1BX2, Subunit B, Seq Identity:100%, Immunoglobulin C1-set domain

UniProt annotation for 2B1F_HUMAN » HLA class II histocompatibility antigen, DRB1-15 beta chain
FUNCTION: Binds peptides derived from antigens that access the endocytic route of antigen presenting cells (APC) and presents them on the cell surface for recognition by the CD4 T-cells. The peptide binding cleft accommodates peptides of 10-30 residues. The peptides presented by MHC class II molecules are generated mostly by degradation of proteins that access the endocytic route, where they are processed by lysosomal proteases and other hydrolases. Exogenous antigens that have been endocytosed by the APC are thus readily available for presentation via MHC II molecules, and for this reason this antigen presentation pathway is usually referred to as exogenous. As membrane proteins on their way to degradation in lysosomes as part of their normal turn-over are also contained in the endosomal/lysosomal compartments, exogenous antigens must compete with those derived from endogenous components. Autophagy is also a source of endogenous peptides, autophagosomes constitutively fuse with MHC class II loading compartments. In addition to APCs, other cells of the gastrointestinal tract, such as epithelial cells, express MHC class II molecules and CD74 and act as APCs, which is an unusual trait of the GI tract. To produce a MHC class II molecule that presents an antigen, three MHC class II molecules (heterodimers of an alpha and a beta chain) associate with a CD74 trimer in the ER to form a heterononamer. Soon after the entry of this complex into the endosomal/lysosomal system where antigen processing occurs, CD74 undergoes a sequential degradation by various proteases, including CTSS and CTSL, leaving a small fragment termed CLIP (class-II-associated invariant chain peptide). The removal of CLIP is facilitated by HLA-DM via direct binding to the alpha-beta-CLIP complex so that CLIP is released. HLA-DM stabilizes MHC class II molecules until primary high affinity antigenic peptides are bound. The MHC II molecule bound to a peptide is then transported to the cell membrane surface. In B-cells, the interaction between HLA-DM and MHC class II molecules is regulated by HLA-DO. Primary dendritic cells (DCs) also to express HLA-DO. Lysosomal microenvironment has been implicated in the regulation of antigen loading into MHC II molecules, increased acidification produces increased proteolysis and efficient peptide loading.

SUBUNIT: Heterodimer of an alpha and a beta subunit; also referred as MHC class II molecule. In the endoplasmic reticulum (ER) it forms a heterononamer; 3 MHC class II molecules bind to a CD74 homotrimer (also known as invariant chain or HLA class II histocompatibility antigen gamma chain). In the endosomal/lysosomal system; CD74 undergoes sequential degradation by various proteases; leaving a small fragment termed CLIP on each MHC class II molecule. MHC class II molecule interacts with HLA_DM, and HLA_DO in B-cells, in order to release CLIP and facilitate the binding of antigenic peptides.

MISCELLANEOUS: The chain shown constituted about 70% of a pool of at least seven similar beta chains.

UniProt features for 2B1F_HUMAN » HLA class II histocompatibility antigen, DRB1-15 beta chain
SIGNAL 1 29
CHAIN 30 266 HLA class II histocompatibility antigen, DRB1-15 beta chain.
DOMAIN 126 214 Ig-like C1-type.
REGION 30 124 Beta-1.
REGION 125 227 Beta-2.
DISULFID 44 108
DISULFID 146 202
CROSSLNK 254 254 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin) (By similarity).
Amino Acid Sequence for 2B1F_HUMAN » HLA class II histocompatibility antigen, DRB1-15 beta chain
MVCLKLPGGS CMTALTVTLM VLSSPLALSG DTRPRFLWQP KRECHFFNGT ERVRFLDRYF YNQEESVRFD SDVGEFRAVT ELGRPDAEYW NSQKDILEQA RAAVDTYCRH NYGVVESFTV QRRVQPKVTV YPSKTQPLQH HNLLVCSVSG FYPGSIEVRW FLNGQEEKAG MVSTGLIQNG DWTFQTLVML ETVPRSGEVY TCQVEHPSVT SPLTVEWRAR SESAQSKMLS GVGGFVLGLL FLGAGLFIYF RNQKGHSGLQ PTGFLS